LabConnect has introduced the smartphone-based SampleGISTICS 2.0 application to digitise clinical trial sample capture.
With the new application, clinical research staff will be able to scan, record, and transmit participant sample information through a mobile device.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
This solution replaces LabConnect’s previous digital pen system and updates processes around sample collection and data entry.
The development of SampleGISTICS 2.0 is based on insights from millions of samples gathered in global clinical trials.
The application targets the removal of manual data entries, paper-based requisitions, and disconnected courier workflows that can result in restricted operational transparency, shipment delays, and lost samples.
It supports research sites with features such as multilingual support, offline functionality, and barcode scanning for consistent performance across diverse settings.
This enables fast management of requisitioning, shipment tracking, and sample collection from smartphones or tablets while supporting same-day collection of data and improved compliance with study protocols.
SampleGISTICS 2.0 delivers real-time visibility into samples’ status, stability, and location from initial collection through laboratory intake.
Its protocol-aligned workflows aim to reduce data entry errors and support proper kit usage for downstream shipment and laboratory processing.
LabConnect CEO Wes Wheeler said: “SampleGISTICS 2.0 is the result of our more than two decades of experience managing decentralised clinical trials across our global network of laboratories, couriers and operations.
“That level of expertise and integration made it possible to develop a new application designed specifically for clinical trials by digitising sample capture at the collection point.”
LabConnect chief technology officer Charles Castano said: “SampleGISTICS 2.0 simplifies how sites handle study visit and participant data at the point of collection, securely transferring it into LabConnect’s validated LIMS environment.
“By leveraging technology to streamline data capture at the site, we can significantly reduce queries and gain visibility into samples arriving close to expiration windows that require priority processing.”
In November 2024, Slope and LabConnect launched a bidirectional application programming interface (API) integration for the clinical trial industry.
